0001731122-24-000010.txt : 20240103 0001731122-24-000010.hdr.sgml : 20240103 20240103205720 ACCESSION NUMBER: 0001731122-24-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231226 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Argen John CENTRAL INDEX KEY: 0001448356 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35384 FILM NUMBER: 24509533 MAIL ADDRESS: STREET 1: 875 MERRICK AVENUE CITY: WESTBURY STATE: NY ZIP: 11590 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Data Storage Corp CENTRAL INDEX KEY: 0001419951 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology IRS NUMBER: 980530147 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 48 SOUTH SERVICE ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 212-564-4922 MAIL ADDRESS: STREET 1: 48 SOUTH SERVICE ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Euro Trend Inc. DATE OF NAME CHANGE: 20071130 4 1 ownership.xml X0508 4 2023-12-26 0 0001419951 Data Storage Corp DTST 0001448356 Argen John C/O DATA STORAGE CORPORATION 48 SOUTH SERVICE ROAD, SUITE 203 MELVILLE NY 11747 1 0 0 0 0 Common Stock 2023-12-26 4 M 0 833 2.04 A 16667 D Common Stock 2023-12-31 4 M 0 2500 A 19167 D Common Stock 2023-12-31 4 A 0 2500 0 A 21667 D Option to Purchase Stock 2.04 2023-12-26 4 M 0 833 0 D 2023-09-30 2032-09-30 Common Stock 2500 1667 D Restricted Stock Unit 2023-12-31 4 M 0 2500 0 D Common Stock 2500 5000 D Option to Purchase Stock 2.88 2023-12-31 4 A 0 2500 0 A 2033-12-30 Common Stock 2500 2500 D Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Represents the shares of the Issuer's common stock underlying an RSU grant to Mr. Argen on December 31, 2023, which RSUs vest on the one-year anniversary of the date of grant. On December 31, 2022 the reporting person was granted 2,500 RSUs, which vested on December 31, 2023. These options ("Options") vest and become exercisable in three equal annual installments over the three-year period measured from December 31, 2023, vesting commencing on December 31, 2024. These Options will expire on December 30, 2033. On December 26, 2023 the reporting person exercised 833 of the 2,500 options granted on September 30, 2022. /s/ Wendy Schmittzeh, Attorney-in-fact 2024-01-03 EX-24 2 e5309_ex24.htm EXHIBIT 24

EXHIBIT 24

POWER OF ATTORNEY

Know all by these present that the undersigned hereby constitutes and appoints each of Chris Panagiotakos and/or Wendy Schmittzeh their true and lawful attorney-in-fact to:

1. execute for and on behalf of the undersigned Schedules 13D and 13G, Form ID, and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder;

2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Schedules 13D or 13G, Form ID application for EDGAR codes, and Forms 3, 4 or 5, and the timely filing of such Forms with the United States Securities and Exchange Commission and any other authority; and

3. take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, including, without limitation, the execution and filing of a Form 4 with respect to a transaction which may be reported on a Form 5, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as he might or could do in person, with full power of substitution and resubstitution, hereby ratifying and confirming all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Sections 13 and 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Schedules 13D and 13G and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Exchange Act and the rules thereunder with respect to the undersigned’s holdings of and transactions in securities issued by Virpax Pharmaceuticals, Inc., its predecessors or assigns, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of November 14, 2023.

	/s/ John Argen
	By: John Argen